PubMed ID: 8862067
Author(s): Ip M, Gorin MB. Recurrence of a choroidal neovascular membrane in a patient with punctate inner choroidopathy treated with daily doses of thalidomide. Am J Ophthalmol. 1996 Oct;122(4):594-5.
Journal: American Journal Of Ophthalmology, Volume 122, Issue 4, Oct 1996
PURPOSE To determine whether thalidomide therapy can prevent a recurrence of a choroidal neovascular membrane in a patient with punctate inner choroidopathy.
METHODS Case report. In a 38-year-old woman with bilateral punctate inner choroidopathy, thalidomide therapy was initiated three days after laser photocoagulation of a choroidal neovascular membrane.
RESULTS The patient had a recurrence of the choroidal neovascular membrane eight months after the start of thalidomide therapy.
CONCLUSIONS The failure of thalidomide to prevent a recurrence of a choroidal neovascular membrane in this patient suggests that this medication may have only a limited benefit in preventing recurrences of choroidal neovascular membranes.